申请人:Yagi Makoto
公开号:US20100298557A1
公开(公告)日:2010-11-25
Disclosed is a novel compound having Syk and/or Abl inhibitory activities, which is useful for prevention/treatment of allergic diseases, autoimmune diseases, arthritides and cancers. Specifically disclosed is a pyrazolopyrimidine compound represented by the formula [I] or [III] below, a tautomer thereof, a stereoisomer thereof, a pharmaceutically acceptable salt thereof, or a solvent of any of them.
本发明公开了一种具有Syk和/或Abl抑制活性的新化合物,其可用于预防/治疗过敏性疾病、自身免疫性疾病、关节炎和癌症。具体公开了一种由下式[I]或[III]表示的吡唑嘧啶化合物,其互变异构体、立体异构体、其药学上可接受的盐或任何它们的溶剂。